Bio-Rad Laboratories Class A
236 hedge funds and large institutions have $2.74B invested in Bio-Rad Laboratories Class A in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 85 increasing their positions, 83 reducing their positions, and 18 closing their positions.
4,566% more call options, than puts
Call options by funds: $2.85M | Put options by funds: $61K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
39% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 18
8% more capital invested
Capital invested by funds: $2.53B → $2.74B (+$203M)
1.81% more ownership
Funds ownership: 76.97% → 78.78% (+1.8%)
2% more funds holding
Funds holding: 232 → 236 (+4)
2% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 83
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Corvex Management
New York
|
+$69.5M |
| 2 |
Morgan Stanley
New York
|
+$21M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$20.7M |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$11.5M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$9.98M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$14.8M |
| 2 |
Renaissance Technologies
New York
|
-$13.9M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$10.3M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$9.26M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$7.89M |
BIO Hedge Fund Activity: Q2 2016 in Review
236 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2016, worth a combined $2.74B — up 8% from $2.53B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new BIO positions and 18 closed out — a net gain of 7 holders — while 85 added to existing stakes and 83 trimmed.
The largest buyer was Corvex Management, opening a new position worth an estimated $69.5M. The largest seller was BlackRock Advisors, cutting an estimated $14.8M.
- 236 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2016, up from 232 in Q1 2016.
- Funds reported $2.74B of Bio-Rad Laboratories Class A stock for Q2 2016, up 8% quarter-over-quarter.
- 25 funds opened new Bio-Rad Laboratories Class A positions in Q2 2016 and 18 closed out, a net change of +7 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q2 2016 was Corvex Management, an estimated $69.5M added.
- The largest Bio-Rad Laboratories Class A seller in Q2 2016 was BlackRock Advisors, an estimated $14.8M sold.
Based on aggregated 13F filings for Q2 2016.